Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» generics

Most Recent

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: Endo to Pay $8 Billion for Par

Endo to Pay $8 Billion for Par

By | May 19, 2015

The deal would create one of the five biggest generic drugmakers in the U.S.

0 Comments

image: Drugmaker Teva Bids $40 Billion for Mylan

Drugmaker Teva Bids $40 Billion for Mylan

By | April 23, 2015

The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.

0 Comments

image: Opinion: Parachuting off the Patent Cliff

Opinion: Parachuting off the Patent Cliff

By | December 6, 2012

As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.

4 Comments

Advertisement
QIAGEN ingenuity
QIAGEN ingenuity

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. A Scrambled Mess
    Features A Scrambled Mess

    Why do so many human eggs have the wrong number of chromosomes?

Advertisement
Diagenode
Diagenode
Advertisement
RayBioTech